News from endo international plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 24, 2023, 07:30 ET Endo Announces Agreement with MAIA Pharmaceuticals to Distribute Bivalirudin Injection in Ready-to-Use Vials

Endo International plc (OTC: ENDPQ) announced today that its subsidiary Endo Ventures Limited has executed an agreement with MAIA Pharmaceuticals,...

May 08, 2023, 07:30 ET ENDO REPORTS FIRST-QUARTER 2023 FINANCIAL RESULTS

Endo International plc (OTC: ENDPQ) today reported financial results for the first-quarter ended March 31, 2023. FIRST-QUARTER FINANCIAL PERFORMANCE...

Apr 26, 2023, 07:30 ET Endo Announces Agreement with Slayback Pharma to Distribute Prevduo™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Product in the U.S.

Endo International plc (OTC: ENDPQ) announced today that its subsidiaries Endo Ventures Limited and Par Pharmaceutical, Inc. (collectively "Endo")...

Apr 17, 2023, 07:45 ET Endo Announces Launch of Argatroban Injection Through Premier's ProRx® Private-Label Program

Endo International plc (OTC: ENDPQ) announced today that its Par Sterile Products business has begun shipping argatroban injection to healthcare...

Apr 03, 2023, 16:30 ET Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Oral Suspension

Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping the authorized...

Mar 13, 2023, 16:15 ET Endo Provides Top-Line Results from Phase 2 Study of Collagenase Clostridium Histolyticum (CCH) in Participants With Plantar Fibromatosis

Endo International plc (OTC: ENDPQ) today announced top-line results from its Phase 2 clinical study of collagenase clostridium histolyticum (CCH) in ...

Mar 10, 2023, 07:30 ET Endo Launches First Generic Version of Pylera® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) Capsules

Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping the first...

Mar 06, 2023, 08:50 ET ENDO REPORTS FOURTH-QUARTER 2022 FINANCIAL RESULTS

Endo International plc (OTC: ENDPQ) today reported financial results for the fourth-quarter ended December 31, 2022. FOURTH-QUARTER FINANCIAL...

Feb 06, 2023, 07:30 ET Endo Launches "Man With a Plan" Campaign to Support Men With Symptoms of Peyronie's Disease

Endo International plc (OTC: ENDPQ) announced today the launch of the "Man With a Plan" campaign, which aims to motivate men who may have symptoms of ...

Dec 06, 2022, 16:45 ET Endo to Cease Production and Sale of Qwo® (collagenase clostridium histolyticum-aaes)

Endo International plc (OTC: ENDPQ) announced today that it will cease the production and sale of Endo Aesthetics' Qwo® (collagenase clostridium...

Nov 09, 2022, 08:30 ET ENDO REPORTS THIRD-QUARTER 2022 FINANCIAL RESULTS

Endo International plc (OTC: ENDPQ) today reported financial results for the third-quarter ended September 30, 2022. THIRD-QUARTER FINANCIAL...

Oct 27, 2022, 07:30 ET Endo and SMSNA Launch App to Provide Peyronie's Disease Self-Assessment Tool

Endo International plc (OTC: ENDPQ) and the Sexual Medicine Society of North America (SMSNA) announced today the launch of a Peyronie's...

Oct 07, 2022, 07:30 ET Endo Presents New Qwo® (collagenase clostridium histolyticum-aaes) Data at the American Society for Dermatologic Surgery's Annual Meeting

Endo International plc (OTC: ENDPQ) announced today that data from studies of Endo Aesthetics' Qwo® (collagenase clostridium histolyticum-aaes), an...

Oct 05, 2022, 07:30 ET Endo Launches Unscripted Video Series With Real Dupuytren's Contracture Patients

Endo International plc (OTC: ENDPQ) announced today the launch of its new branded video series, Coffee & Cords, which aims to educate people about...

Aug 16, 2022, 22:00 ET Endo Enters Into Restructuring Support Agreement with Senior Secured Debtholders to Strengthen Financial Position and Advance Ongoing Business Transformation

Endo International plc (NASDAQ: ENDP) ("Endo" or the "Company") today announced that it has entered into a restructuring support agreement ("RSA")...

Aug 09, 2022, 08:45 ET ENDO REPORTS SECOND-QUARTER 2022 FINANCIAL RESULTS

Endo International plc (NASDAQ: ENDP) today reported financial results for the second-quarter ended June 30, 2022. SECOND-QUARTER FINANCIAL...

Jul 15, 2022, 07:30 ET Endo Announces Agreement for Paladin Labs to Develop, Commercialize and Supply Quoin Pharmaceuticals' QRX003 in Canada

Endo International plc (NASDAQ: ENDP) announced today that its subsidiary Endo Ventures Limited has entered into agreements with Quoin...

Jul 01, 2022, 13:32 ET Opana® ER Antitrust Trial Concludes With Jury Verdict in Endo's Favor

Endo International plc (NASDAQ: ENDP) announced today that a federal jury in Chicago, Illinois, has returned a verdict in favor of the Company's...

Jul 01, 2022, 07:30 ET Endo Provides Top-Line Results from Phase 2 Study of Collagenase Clostridium Histolyticum (CCH) in Participants with Adhesive Capsulitis of the Shoulder

Endo International plc (NASDAQ: ENDP) today announced top-line results from its Phase 2 study of Collagenase Clostridium Histolyticum (or "CCH") in...

Jun 13, 2022, 06:30 ET Endo Executes Agreement With TLC to Commercialize Phase 3 Orthopedic Product for the Treatment of Osteoarthritis Knee Pain

Endo International plc (NASDAQ: ENDP) announced today that its subsidiary Endo Ventures Limited (EVL) has executed an agreement with Taiwan Liposome...

Jun 09, 2022, 08:00 ET National Survey of Over 1,500 Men Shows More Than Half Were Unsure of How to Improve Their Mental and Sexual Health; New Partnership Aims to Change That Through Education and Free Virtual Consultations

Endo, Vault Health, the Sexual Medicine Society of North America (SMSNA) and Men's Health Network (MHN) join forces to launch Healthy Now: A Men's...

May 05, 2022, 16:30 ET ENDO REPORTS FIRST-QUARTER 2022 FINANCIAL RESULTS

Endo International plc (NASDAQ: ENDP) today reported financial results for the first-quarter ended March 31, 2022 and provided second-quarter 2022...

May 05, 2022, 16:20 ET Endo Aesthetics to Introduce New Clinical Study of Qwo® (collagenase clostridium histolyticum-aaes) at the Annual SCALE Meeting

Endo International plc (NASDAQ: ENDP) today announced the upcoming launch of a new clinical study relevant to the use of Qwo® (collagenase...

May 02, 2022, 07:55 ET Endo Acquires Six Development-Stage, Ready-to-Use Injectable Product Candidates From Nevakar

Endo International plc (NASDAQ: ENDP) announced today that its subsidiary Endo Ventures Limited (EVL) acquired six development-stage, ready-to-use...

Apr 20, 2022, 17:23 ET Tennessee Court of Appeals Orders Recusal of Trial Court Judge and Vacates Default Judgment on Liability Against Endo

Endo International plc (NASDAQ: ENDP) today announced that the Tennessee Court of Appeals has reversed a trial court judge's order denying a motion...